Lung Cancer Screening Does Not Increase Unnecessary Surgery Rates
the ONA take:
Lung cancer screening programs result in a low incidence of surgical intervention for non-lung cancer diagnoses and a rare incidence of surgical intervention for benign disease, a new study published in the journal The Annals of Thoracic Surgery has shown.
For the study, researchers at Lahey Hospital & Medical Center retrospectively analyzed the surgical outcomes of 25 of the 1,654 patients who underwent low-dose computer tomography lung cancer screening.
Results showed that of the 25 that underwent surgery, five had non-lung cancer diagnoses, equating to an incidence of surgery for non-lung cancer diagnosis of 0.30%.
Researchers found that the incidence of surgery for benign disease was 0.24%. The other 20 patients had lung cancer, of which 18 had early stage disease and two had late stage disease.
“Lung cancer screening saves lives, and our study serves as a model for how to set up a screening program that is safe and effective for patients,” said Christina Williamson, MD, from Lahey Hospital & Medical Center.
“It is only by minimizing the number of operations for benign disease and maintaining a low morbidity and mortality for surgical resection that the full benefit of lung cancer screening can be realized in its widespread adoption in clinical practice,” Williamson said.
Lung cancer screening programs result in a low incidence of surgical intervention for non-lung cancer diagnoses.
- FDA Grants Approval to Bevacizumab-awwb as First Biosimilar for Anticancer Therapy
- Efficacy of Octreotide LAR, Lanreotide in Management of Carcinoid Tumors
- Multivitamin Use May Reduce Risk of Chemo-Induced Neuropathy
- Overall Survival in Advanced Melanoma Improved With Nivolumab, Ipilimumab Combination
- Adjuvant Durvalumab Therapy May Prolong Progression-free Survival in NSCLC
- Invisible Burdens: The Complex Needs of Caregivers of Patients With Brain Cancer
- Cannabis Reduces Response Rate to Immunotherapy for Cancer
- Perioperative Blockade of Pathways May Improve Outcomes in Breast Cancer
- Zika Virus Preferentially Targets Glioblastoma Stem Cells
- Daratumumab Infusion-Related Reactions Managed by Pre/Postinfusion Medications
- Lorazepam Plus Haloperidol Improves Agitation in Cancer-Related Delirium
- Cost of Care Significantly Increased With Carcinoid Syndrome in NETs
- Treating Intractable Hiccups in Advanced Cancer, Palliative Care Setting
- Severe Mental Illness May Worsen Breast Cancer Survival Outcomes
- Imaging Management of Breast Density, a Controversial Risk Factor for Breast Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|